Rheumatology 2002; 41: 619-630
© 2002 British Society for Rheumatology
Reviews |
The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation
Department of Neurology and
1 Department of Rheumatology and Clinical Immunology, University Medical Centre, Utrecht, The Netherlands
Objectives. To identify the pathogenetic mechanisms of central nervous system (CNS) syndromes of systemic lupus erythematosus (SLE) as described in the literature.
Methods. Using PUBMED, we performed a systematic search of publications from 1980 onwards. Studies were eligible if they had been performed on patients or material from patients with CNS manifestations and definite SLE and when the CNS manifestations were not secondary. Criteria were formulated for the identification of pathogenetic mechanisms.
Results. The single most important cause of the CNS syndromes of SLE is ischaemia due to narrowing or occlusion of small vessels, arteries and veins. Antiphospholipid antibodies and premature atherosclerosis play roles in these processes, but they have not been delineated definitely. Intracranial and intraspinal haemorrhages are much less frequent than ischaemia and are presumably in part due directly to SLE. Vasculitis may cause ischaemia or haemorrhage in the CNS and is involved occasionally, as shown by imaging and histological findings. White matter damage is heterogeneous and ill-understood. It includes white matter degeneration and myelin vacuolation of the spinal cord, and reversible leucoencephalopathy due to oedema. Antibody-induced neuronal dysfunction in the CNS is a realistic hypothesis and may involve anti-ribosomal P antibodies and several other antibodies. Deficiency of psychological reactions forms a separate and entirely different category of mechanisms.
Conclusions. Causes have been identified or possible causes have been suggested for most of the CNS syndromes of SLE, thus offering rationales for different forms of prevention and therapy.
KEY WORDS: Systemic lupus erythematosus, Central nervous system-syndromes, Pathogenesis, Nomenclature.
Correspondence to: L. Kater, Bevelandselaan 11, 1181 JL Amstelveen, The Netherlands.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Langosch, S. Rand, B. Ghosh, S. Sharma, C. Tench, R. Stratton, D. D'Cruz, M. Trimble, G. Barrett, and H. Ring A Clinical Electrophysiological Study of Emotional Lability in Patients With Systemic Lupus Erythematosus J Neuropsychiatry Clin Neurosci, May 1, 2008; 20(2): 201 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Theodoridou and L Settas Demyelination in rheumatic diseases Postgrad. Med. J., March 1, 2008; 84(989): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bartolucci, S. Brechignac, P. Cohen, V. Le Guern, and L. Guillevin Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients Lupus, October 1, 2007; 16(10): 817 - 822. [Abstract] [PDF]
|
|
|
|
|
|
M.L. Ishimori, B.D. Pressman, D.J. Wallace, and M.H. Weisman Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus, June 1, 2007; 16(6): 436 - 443. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Parikh, K. Shifteh, M.L. Lipton, J.A. Bello, and A.L. Brook Deep Brain Reversible Encephalopathy: Association with Secondary Antiphospholipid Antibody Syndrome AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 76 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Theodoridou and L Settas Demyelination in rheumatic diseases. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 290 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Jacobi, K Stingele, R Kretz, M Hartmann, B Storch-Hagenlocher, A Breitbart, and B Wildemann Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus Lupus, February 1, 2006; 15(2): 107 - 109. [Abstract] [PDF]
|
|
|
|
 |
|
 G Castellino, M Govoni, M Padovan, P Colamussi, M Borrelli, and F Trotta Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up Ann Rheum Dis, July 1, 2005; 64(7): 1022 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ferreira, D. P. D'Cruz, and G. R. V. Hughes Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology, April 1, 2005; 44(4): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P L Peterson, F A Howe, C A Clark, and J S Axford Quantitative magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus Lupus, December 1, 2003; 12(12): 897 - 902. [Abstract] [PDF]
|
|
|
|
|
|
N J Abbott, L L. Mendonca, and D E. Dolman The blood-brain barrier in systemic lupus erythematosus Lupus, December 1, 2003; 12(12): 908 - 915. [Abstract] [PDF]
|
|
|
|
|
|
P L Meroni, A Tincani, N Sepp, E Raschi, C Testoni, E Corsini, I Cavazzana, S Pellegrini, and A Salmaggi Endothelium and the brain in CNS lupus Lupus, December 1, 2003; 12(12): 919 - 928. [Abstract] [PDF]
|
|
|
|
|
|
R. Jain, J. Deveikis, S. Hickenbottom, and S. K. Mukherji Varicella-Zoster Vasculitis Presenting with Intracranial Hemorrhage AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 971 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sanna, M. L. Bertolaccini, M. J. Cuadrado, M. A. Khamashta, and G. R. V. Hughes Central nervous system involvement in the antiphospholipid (Hughes) syndrome Rheumatology, February 1, 2003; 42(2): 200 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. I. Jennekens and L. Kater The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation Rheumatology, June 1, 2002; 41(6): 605 - 618. [Abstract] [Full Text] [PDF]
|
|